SCHEMBL9973716

SCHEMBL9973716

c1cncc(-c2ccc(-c3ccc4c5ccc(-c6ccc(-c7cccnc7)nc6)cc5n(-c5ccc6ccccc6c5)c4c3)cn2)c1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.53
CYP11B1 P15538 5/20 0.53
CYP19A1 P11511 4/20 0.53
CYP17A1 P05093 3/20 0.53
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP2A6 P11509 3/20 0.41
CYP3A4 P08684 1/20 0.40
MAPK9 P45984 3/20 0.40
MAPK10 P53779 3/20 0.40
ERN1 O75460 1/20 0.40
FGFR1 P11362 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPK1 P28482 1/20 0.39
MAPK8 P45983 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9973719 0.91 CYP11B2 (0.53) CYP11B2CYP11B1CYP19A1CYP17A1MAPT
SCHEMBL9973717 0.87 METAP2 (0.45) CYP11B2CYP11B1CYP19A1CYP17A1ALDH1A1
SCHEMBL9973678 0.86 CYP19A1 (0.49) CYP11B2CYP11B1CYP19A1CYP17A1MAPT
SCHEMBL9973757 0.83 CYP19A1 (0.43) CYP11B2CYP11B1CYP19A1CYP17A1MAPT
SCHEMBL22140982 0.82 CYP11B2 (0.61) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL24345161 0.82 CYP19A1 (0.42) CYP11B2CYP11B1CYP19A1CYP17A1MAPT
SCHEMBL9973767 0.82 CYP2A6 (0.45) CYP19A1CYP2A6CYP3A4
SCHEMBL9973715 0.82 CYP11B1 (0.44) CYP11B2CYP11B1CYP19A1CYP17A1CYP2A6
SCHEMBL9973740 0.80 CYP19A1 (0.50) CYP11B2CYP11B1CYP19A1CYP17A1MAPT
SCHEMBL20228601 0.78 CYP11B1 (0.56) CYP11B2CYP11B1CYP19A1CYP17A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202633-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2012-06-19 US disclosed
US-8202633-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2012-06-19 US disclosed
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SK MATERIALS JNC CO., LTD. (KR) 2011-09-08 US disclosed
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SK MATERIALS JNC CO., LTD. (KR) 2011-09-08 US disclosed
US-7964293-B2 Electron transport material and organic electroluminescent device using the same JNC CORPORATION (JP) 2011-06-21 US disclosed
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SK MATERIALS JNC CO., LTD. (KR) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110215310-A1 ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLC25A11, ELAVL1, SLC26A3 CYP11B2 1338/4885CYP11B1 1482/4885CYP19A1 3499/4885
US-20090134780-A1 Electron transport material and organic electroluminescent device using the same SLC25A11, ELAVL1, SLC26A3 CYP11B2 1338/4885CYP11B1 1482/4885CYP19A1 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.